# Smartphone Based-PPG Assessment of REconversion in Persistent Atrial Fibrillation

Study · id `cardio:ct-nct07752940` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07752940](<https://clinicaltrials.gov/study/NCT07752940>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07752940

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07752940. Randomized; no masking; primary purpose health services research. Start 2026-08-01 (anticipated); primary completion 2027-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07752940, source copy `cardio:ctgov-nct07752940-2026-08-07`, retrieved 2026-10-26)
- Planned start: 2026-08-01 (anticipated) (ClinicalTrials.gov record NCT07752940, source copy `cardio:ctgov-nct07752940-2026-08-07`, retrieved 2026-10-26)
- Primary completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT07752940, source copy `cardio:ctgov-nct07752940-2026-08-07`, retrieved 2026-10-26)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07752940, source copy `cardio:ctgov-nct07752940-2026-08-07`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT07752940, source copy `cardio:ctgov-nct07752940-2026-08-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07752940-2026-08-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Smartphone Based-PPG Assessment of REconversion in Persistent Atrial Fibrillation
- Acronym: SPARE-AF
- Condition: Atrial Fibrillation (AF)
- Intervention (Device): Smartphone-based PPG monitoring
- Lead sponsor: Ziekenhuis Oost-Limburg
- Lead sponsor class: OTHER
- Collaborator: Universitaire Ziekenhuizen KU Leuven
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Ziekenhuis Oost-Limburg (`cardio:org-ziekenhuis-oost-limburg`)
- Registry lists this organization as a collaborator: Universitaire Ziekenhuizen KU Leuven (`cardio:org-universitaire-ziekenhuizen-ku-leuven`)

## Provenance

Content hash: f657e0ca1865ca8375c99e154e97bfcda2a735538932577881e6b30ee705297b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
